Company / FCF Margin
Arcadia Biosciences, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-191.1%
FY2025
5-year range
-405.2% / -189.4%
FY2021-FY2025
Trend
+44.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -1597.5% in FY2020 to -189.4% in FY2023.
Based on SEC 10-K filings.
-191.1% in FY2025 with a 5-year CAGR of +1406.4%.
Remained stable around -191.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +205.3pp
- 5-Year Change
- +1406.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 44.4% year-over-year.
- Peak fcf margin was recorded in FY2023.
- Lowest fcf margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -191.1% | +44.4% |
| FY2024 | -343.5% | -81.4% |
| FY2023 | -189.4% | +52.2% |
| FY2022 | -396.4% | +2.2% |
| FY2021 | -405.2% | +74.6% |
| FY2020 | -1597.5% | -68.5% |
| FY2019 | -948.2% | -171.8% |
| FY2018 | -348.8% | +35.7% |
| FY2017 | -542.2% | -92.4% |
| FY2016 | -281.9% | -31.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026